Assure Holdings Corp. (IONM) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Assure Holdings Corp. (IONM) trades at $0.0005 with AI Score 36/100 (Grade D). Assure Holdings Corp. provides intraoperative neuromonitoring services for spine and head surgeries, operating in multiple states across the U. S. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for IONM: IONM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IONM against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IONM: 3/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Assure Holdings Corp. (IONM) Healthcare & Pipeline Overview
Assure Holdings Corp. specializes in intraoperative neuromonitoring, offering real-time surgical support services primarily for spine and head procedures across several U.S. states. Facing a competitive landscape in medical care facilities, Assure focuses on delivering clinical and operational services to surgeons and medical facilities.
What Is the Investment Thesis for IONM?
Assure Holdings Corp. operates in the niche market of intraoperative neuromonitoring, a critical service for surgeries involving the spine and head. The increasing volume of these surgeries, coupled with the growing awareness of the importance of neuromonitoring to reduce surgical complications, presents a potential growth opportunity. However, with a negative profit margin of -10226.7% and a negative gross margin of -860.4%, the company faces significant challenges in achieving profitability. Key value drivers include expanding service offerings and increasing market penetration in existing and new geographic regions. The company's ability to secure contracts with more hospitals and surgical centers will be crucial for revenue growth. Investors should closely monitor the company's efforts to improve its financial performance and achieve sustainable profitability.
Based on FMP financials and quantitative analysis
IONM Key Highlights
Assure Holdings Corp. specializes in intraoperative neuromonitoring (IONM) services, a critical component in spine and head surgeries.
- The company operates in 12 states across the U.S., providing services to a diverse range of medical institutions.
- Assure Holdings offers a comprehensive suite of services, including scheduling, real-time monitoring, patient advocacy, and billing support.
- The company's profit margin is -10226.7%, indicating significant challenges in achieving profitability.
- Assure Holdings Corp. has a beta of 1.88, suggesting higher volatility compared to the market.
Who Are IONM's Competitors?
IONM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BICX BioCorRx Inc. | $0.24 | +0.00% | $6.34M | 52 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
| JYNT The Joint Corp. | $8.25 | +0.24% | $118M | 75 |
| HWAIF Healwell AI Inc. | $0.57 | +3.64% | $172M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IONM's Key Strengths?
Specialized expertise in intraoperative neuromonitoring.
- Established relationships with hospitals and surgeons.
- Geographic presence in multiple states.
- Comprehensive suite of clinical and operational services.
What Are IONM's Weaknesses?
Negative profit margin indicates financial instability.
- High operating costs relative to revenue.
- Dependence on a limited number of surgical procedures.
- Limited brand recognition compared to larger competitors.
What Could Drive IONM Stock Higher?
Potential for new contracts with hospitals and surgical centers.
- Expansion of service offerings to include additional surgical procedures.
- Efforts to improve financial performance and achieve profitability.
What Are the Key Risks for IONM?
Financial-distress signal — its Altman Z-Score of -36.96 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger neuromonitoring service providers.
- Changes in healthcare regulations and reimbursement policies.
- Negative profit margin indicates financial instability.
- Economic downturns that could reduce surgical volumes.
What Are the Growth Opportunities for IONM?
- Expansion into New Geographic Markets: Assure Holdings has the opportunity to expand its services into additional states and regions within the U.S. The market for intraoperative neuromonitoring is growing, driven by the increasing volume of spine and head surgeries. Entering new markets would allow Assure to increase its revenue base and diversify its operations. The timeline for expansion could be within the next 1-3 years, focusing on regions with a high volume of surgical procedures and a need for specialized neuromonitoring services.
- Increasing Service Penetration in Existing Markets: Assure Holdings can focus on increasing its market share in the states where it currently operates. This can be achieved by securing contracts with more hospitals, surgical centers, and physician groups. By demonstrating the value and reliability of its services, Assure can attract new clients and increase its revenue per client. The timeline for this strategy is ongoing, with continuous efforts to build relationships and secure new contracts.
- Development of New Service Offerings: Assure Holdings can expand its service offerings to include additional types of surgical procedures and monitoring techniques. This could involve incorporating advanced technologies and developing specialized protocols for different surgical specialties. By offering a broader range of services, Assure can attract a wider range of clients and increase its revenue potential. The timeline for developing new service offerings could be within the next 2-4 years, requiring investment in research, training, and technology.
- Strategic Partnerships and Acquisitions: Assure Holdings can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. Partnering with complementary service providers or acquiring smaller neuromonitoring companies could provide access to new technologies, expertise, and client relationships. This strategy could accelerate Assure's growth and strengthen its competitive position. The timeline for strategic partnerships and acquisitions is opportunistic, depending on the availability of suitable targets and the alignment of strategic goals.
- Leveraging Technology for Efficiency and Scalability: Assure Holdings can invest in technology to improve the efficiency and scalability of its operations. This could involve implementing advanced monitoring systems, data analytics tools, and telemedicine solutions. By leveraging technology, Assure can reduce its operating costs, improve the quality of its services, and expand its capacity to serve more clients. The timeline for technology investments is ongoing, with continuous efforts to identify and implement innovative solutions.
What Are IONM's Competitive Advantages?
- Specialized expertise in intraoperative neuromonitoring.
- Established relationships with hospitals and surgeons.
- Geographic presence in multiple states.
- Comprehensive suite of clinical and operational services.
What Does IONM Do?
Assure Holdings Corp., through its subsidiaries, is dedicated to providing technical and professional intraoperative neuromonitoring (IONM) surgical support services. These services are primarily utilized during spine and head surgeries, where real-time monitoring of the patient's nervous system is critical to prevent surgical complications. The company's comprehensive suite of services includes the scheduling of interoperative neurophysiologists and supervising practitioners, continuous real-time monitoring during procedures, patient advocacy, and complete billing services. Assure Holdings aims to support surgeons and medical facilities by ensuring that invasive procedures are conducted with the highest degree of neurological safety. The company operates across multiple states, including Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah. This widespread presence allows Assure Holdings to serve a diverse range of medical institutions and patients. Headquartered in Englewood, Colorado, Assure Holdings Corp. continues to refine its service offerings and expand its geographic footprint to meet the growing demand for IONM services. The company's focus on delivering high-quality clinical support and operational efficiency positions it as a key player in the surgical support services sector.
What Products and Services Does IONM Offer?
- Provides intraoperative neuromonitoring (IONM) services.
- Supports spine and head surgeries with real-time monitoring.
- Schedules interoperative neurophysiologists and supervising practitioners.
- Offers patient advocacy services during surgical procedures.
- Delivers billing services to support medical facilities.
- Operates in multiple states across the United States.
How Does IONM Make Money?
- Generates revenue by providing IONM services during surgical procedures.
- Contracts with hospitals, surgical centers, and physician groups.
- Charges fees for the scheduling, monitoring, and billing services provided.
- Revenue is dependent on the volume of surgeries and the number of contracts secured.
What Industry Does IONM Operate In?
Assure Holdings Corp. operates within the medical care facilities industry, which is experiencing growth due to the increasing volume of surgical procedures and the rising demand for specialized surgical support services. The market for intraoperative neuromonitoring is driven by the need to minimize surgical complications and improve patient outcomes. The competitive landscape includes other neuromonitoring service providers and medical technology companies. Assure Holdings differentiates itself through its comprehensive service offerings and geographic reach, operating in 12 states across the U.S.
Who Are IONM's Key Customers?
- Hospitals and surgical centers.
- Surgeons specializing in spine and head procedures.
- Patients undergoing surgeries that require neuromonitoring.
Financial Health
Assure Holdings Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -36.96 places it in the distress zone, a signal of elevated financial risk.
Assure Holdings Corp. (IONM) Valuation Context
Relative to its peer group, IONM's quantitative score of 36/100 is below the peer average of 57/100.
Company Profile
Assure Holdings Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Denver, US. The company is led by CEO John Allen Farlinger. IONM has traded publicly since 2018.
IONM Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying signals confidence, suggesting those closest to the company see potential upside.
- The community buzz is generally positive, with many highlighting potential growth catalysts in the healthcare sector.
- Market perception seems to be improving as Assure Holdings expands its network and service offerings.
- There's a growing belief that the company is undervalued, particularly given its position in a niche market.
Bear Case
- Some insiders recently reduced their holdings, which could indicate concerns about near-term performance.
- Bearish sentiment in the community points to worries about increasing competition in the healthcare space.
- Market perception is still cautious due to past performance issues and slower-than-expected growth.
- There are concerns about regulatory challenges and their potential impact on the company's operations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
IONM Latest News
No recent news available for IONM.
IONM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IONM.
Price Targets
Wall Street price target analysis for IONM.
IONM MoonshotScore
What does this score mean?
The MoonshotScore rates IONM 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: John Allen Farlinger
CEO
John Allen Farlinger serves as the CEO of Assure Holdings Corp. His leadership is pivotal in guiding the company's strategic direction and operational execution. Information regarding his specific background, career history, education, and previous roles is not available in the provided data. However, as CEO, he is responsible for overseeing all aspects of the company's business, including clinical operations, sales and marketing, finance, and administration.
Track Record: As CEO of Assure Holdings Corp., John Allen Farlinger is responsible for the overall performance and strategic direction of the company. Specific achievements and milestones under his leadership are not detailed in the provided data. However, his role involves making key decisions related to the company's growth, profitability, and competitive positioning.
IONM OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Assure Holdings Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries higher risks compared to those listed on major exchanges like the NYSE or NASDAQ due to the lack of stringent listing requirements and regulatory oversight. This tier is often populated by shell companies, bankrupt entities, or companies with questionable business practices.
- OTC Tier: OTC Other
- Limited financial disclosure increases the difficulty of assessing the company's financial health.
- Low trading volume can lead to wider bid-ask spreads and increased volatility.
- The OTC Other tier carries a higher risk of fraud and manipulation.
- Lack of stringent listing requirements and regulatory oversight.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and SEC filings (if available).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and profitability trends.
- Monitor the trading volume and bid-ask spread of the stock.
- Consult with a financial advisor to assess the risks and potential rewards.
- Confirm the company's legal standing and compliance with regulations.
- The company has been in operation for several years.
- Assure Holdings Corp. has a clearly defined business model.
- The company has a website and provides information about its services.
- The company has a management team in place.
- The company operates in a regulated industry.
What Investors Ask About Assure Holdings Corp. (IONM) — Healthcare
What does the AI Score mean for IONM?
IONM holds an AI Score of 36/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Assure Holdings Corp. provides intraoperative neuromonitoring services for spine and head surgeries, operating in multiple states across the U.S. The company supports surgeons and medical …
What does Assure Holdings Corp. do?
Assure Holdings Corp. specializes in providing intraoperative neuromonitoring (IONM) services, which are crucial during surgeries involving the spine and head. The company's services include real-time monitoring of the patient's nervous system to prevent surgical complications, scheduling of neurophysiologists, patient advocacy, and billing services.
What are the main risks for IONM?
Assure Holdings Corp. faces several risks, including its negative profit margin, which indicates financial instability. The company also faces competition from larger neuromonitoring service providers and potential changes in healthcare regulations and reimbursement policies. Economic downturns could reduce surgical volumes, impacting the demand for Assure's services. Additionally, the company's reliance on a limited number of surgical procedures and its OTC listing add to the risk profile.
How does Assure Holdings Corp. generate revenue in the healthcare sector?
Assure Holdings Corp. generates revenue by providing intraoperative neuromonitoring (IONM) services during surgical procedures. The company contracts with hospitals, surgical centers, and physician groups to provide these services. Revenue is generated through fees charged for the scheduling of neurophysiologists, real-time monitoring during surgeries, patient advocacy, and billing services.
What are the key factors to evaluate for IONM?
Assure Holdings Corp. (IONM) holds an AI score of 36/100 (low). operates in the niche market of intraoperative neuromonitoring, a critical service for surgeries involving the spine and head. Not financial advice.
How frequently does IONM data refresh on this page?
IONM's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven IONM's recent stock price performance?
Assure Holdings Corp. (IONM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in intraoperative neuromonitoring. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IONM overvalued or undervalued right now?
Assure Holdings Corp. (IONM) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research IONM before investing?
Before investing in Assure Holdings Corp. (IONM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for Assure Holdings Corp.
- AI analysis pending for IONM stock.